Zusammenfassung
In this review we summarize new developments in early diagnosis, establishing surrogate markers, genetics, neuroprotection and cell replacement in Parkinson's disease. Furthermore, we discuss the major problems in the translation of results from preclinical research into successful clinical trials.
Nur für Besitzer und Autoren: Kontrollseite des Eintrags